Bridging Continents, Accelerating Innovation: Meet Accelagen at BIO Boston
Accelagen is pleased to confirm that Mathew Palmer Chief Growth and Commercial Officer, along with Trent Wadford Senior Director, Business Development will be representing the team at the BIO International Conference 2025 in Boston, 16-19 June. As a growing global force in clinical research, Accelagen is strengthening its presence in the U.S. market — and BIO provides the perfect platform to build meaningful relationships with biotech and pharmaceutical innovators seeking faster, smarter paths to clinical success.
A Proven Partner with Global Reach
With more than three decades of industry experience across clinical operations, project management, and business development, Mat Palmer brings a wealth of knowledge and insight to every conversation. Having attended BIO International multiple times, Mat understands the importance of these face-to-face opportunities to establish the foundations of true, collaborative partnerships — not just vendor contracts.
For Mat and the Accelagen leadership team, partnership is not a transactional event. It’s about becoming an extension of a sponsor’s team — deeply understanding their needs, anticipating challenges, and building customised solutions that lead to long-term success.
Expanding into the U.S. Market with Local Expertise
To better serve U.S. companies, Accelagen recently expanded its footprint by appointing Trent Wadford as a U.S.-based Business Development representative. Trent will be joining Mat at BIO International to meet with new and existing clients, offering American sponsors real-time communication, personalised support, and a direct line into Accelagen’s robust Australian and US operations.
By blending local accessibility with global clinical execution, Accelagen removes traditional barriers and creates a seamless experience for sponsors ready to harness the advantages of conducting early-phase clinical work in Australia.
Why Connect with Accelagen at BIO?
Mat and Trent will be actively meeting with companies throughout BIO International to discuss how Accelagen offers a unique combination of scientific rigor, operational excellence, and true partnership commitment. Some key reasons to meet with them include:
- Australian Advantage: Faster study start-up timelines, more flexible regulatory pathways, and significant cost savings compared to the U.S.
- Integrated Capabilities: End-to-end clinical trial services all based in Australia — no offshored biometrics or fragmented project management.
- Strategic Collaboration: Accelagen emphasises deep collaboration, ensuring every program is designed with your specific needs, milestones, and strategic goals in mind.
- Trusted Relationships: A proven track record of repeat business, a focus on transparency, and an emphasis on building lasting partnerships, not one-off projects.
- Hands-On Expertise: A team that not only listens but proactively builds smarter pathways forward, helping to mitigate risks and optimise clinical outcomes.
For Accelagen, it’s not about presenting a generic capabilities deck — it’s about real conversations, understanding your program’s nuances, and working together to drive success.
Setting Up a Meeting with Mat and Trent
Matt and Trent will be using the BIO One-on-One Partnering platform to schedule meetings throughout the conference. You’ll also be able to find them near the Australian Pavilion as part of the Victorian delegation, and they encourage anyone interested to stop by and say hello.
In addition, if you would like to pre-arrange a time to meet, you can fill out the form at the bottom of this page or reach out through the BIO partnering system directly.
Experience the Accelagen Difference
Accelagen is proud to offer sponsors an alternative to the traditional CRO model — one based on transparency, teamwork, agility, and world-class clinical execution. With an experienced team, a family-like internal culture, and a laser focus on client success, Accelagen is ready to help biotech and pharmaceutical companies bring their therapies to patients faster and more cost-effectively.
Whether you’re exploring first-in-human trials, expanding your early-phase pipeline, or simply seeking a CRO that listens first and delivers always, Mat and Trent would love to meet with you at BIO International.Ready to connect?
Schedule your meeting today — and experience the Accelagen difference for yourself.